It has been shown that SATB1 was overexpressed in a variety of tumor types including breast cancer [11], laryngeal squamous cell carcinoma [12], gastric cancer [13], [14], and malignant cutaneous melanoma [15]. This evidence concerns the gene SATB1 and laryngeal squamous cell carcinoma.